On this page
Francois Nader
Insider
First SEC filing: April 30, 2020 · Latest: April 30, 2020
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | MRNA | A | 6,454 | · | · | 6,454 Direct | · | Acquired | (price as of 2026-10-02) |
| May 6, 2026 | MRNA | A | 4,185 | · | · | 4,185 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2026 | MRNA | M | 12,174 | · | · | 32,781 Direct | +59.08% | Acquired | (price as of 2026-10-02) |
| April 30, 2026 | MRNA | M | 12,174 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 1, 2026 | TECX | A | 20,400 | · | · | 20,400 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | A | 12,174 | · | · | 12,174 Direct | · | Acquired | (price as of 2026-10-02) |
| April 30, 2025 | MRNA | A | 6,378 | · | · | 6,378 Direct | · | Acquired | (price as of 2026-10-02) |
| May 6, 2024 | MRNA | A | 7,557 | · | · | 7,557 Direct | · | Acquired | (price as of 2026-10-02) |
| May 3, 2023 | MRNA | A | 6,134 | · | · | 6,134 Direct | · | Acquired | (price as of 2026-10-02) |
| May 10, 2022 | MRNA | M 10b5-1 | 23,100 | · | · | 16,620 Direct | -58.16% | Disposed | (price as of 2026-10-02) |
| May 10, 2022 | MRNA | S | 3,196 | $136.10 | $434,976 | 20,607 Direct | -13.43% | Disposed | 39.6% (price as of 2026-10-02) |
| May 10, 2022 | MRNA | M 10b5-1 | 23,100 | $18.87 | $435,897 | 23,803 Direct | +3285.92% | Acquired | 906.9% (price as of 2026-10-02) |
| April 28, 2022 | MRNA | A | 5,415 | · | · | 5,415 Direct | · | Acquired | (price as of 2026-10-02) |
| April 28, 2022 | MRNA | M | 703 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 28, 2022 | MRNA | M | 703 | · | · | 703 Direct | · | Acquired | (price as of 2026-10-02) |
| April 28, 2021 | MRNA | A | 4,081 | · | · | 4,081 Direct | · | Acquired | (price as of 2026-10-02) |
| April 28, 2021 | MRNA | A | 703 | · | · | 703 Direct | · | Acquired | (price as of 2026-10-02) |
| April 29, 2020 | MRNA | A | 18,270 | · | · | 18,270 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 10, 2019 | MRNA | A | 17,889 | $18.87 | $337,565 | 17,889 Direct | · | Acquired | 906.9% (price as of 2026-10-02) |
| Dec. 10, 2019 | MRNA | A | 39,720 | $18.87 | $749,516 | 39,720 Direct | · | Acquired | 906.9% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | MRNA | Stock Option (Right to Buy) | Common Stock | $48.79 | May 6, 2036 | 6,454 | Acquired |
| May 6, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 4,185 | Acquired |
| April 30, 2026 | MRNA | Restricted Stock Units | Common Stock | · | · | 12,174 | Disposed |
| April 1, 2026 | TECX | Stock Option (Right to Buy) | Common Stock | $30.78 | March 31, 2036 | 20,400 | Acquired |
| April 30, 2025 | MRNA | Restricted Stock Units | Common Stock | · | · | 12,174 | Acquired |
| April 30, 2025 | MRNA | Stock Option (Right to Buy) | Common Stock | $28.54 | April 30, 2035 | 6,378 | Acquired |
| May 6, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock | $122.13 | May 6, 2034 | 7,557 | Acquired |
| May 3, 2023 | MRNA | Stock Option (Right to Buy) | Common Stock | $130.14 | May 3, 2033 | 6,134 | Acquired |
| May 10, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock | $18.87 | Dec. 10, 2029 | 23,100 | Disposed |
| April 28, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock | $142.52 | · | 5,415 | Acquired |
| April 28, 2022 | MRNA | Restricted Stock Units | Common Stock | $0.00 | · | 703 | Disposed |
| April 28, 2021 | MRNA | Stock Option (Right to Buy) | Common Stock | $178.68 | April 28, 2031 | 4,081 | Acquired |
| April 28, 2021 | MRNA | Restricted Stock Units | Common Stock | $0.00 | · | 703 | Acquired |
| April 29, 2020 | MRNA | Stock Option (Right to Buy) | Common Stock | $46.37 | April 29, 2030 | 18,270 | Acquired |
| Dec. 10, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $18.87 | Dec. 10, 2029 | 17,889 | Acquired |
| Dec. 10, 2019 | MRNA | Stock Option (Right to Buy) | Common Stock | $18.87 | Dec. 10, 2029 | 39,720 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).